全体要約
表現型創薬市場は、2022年の売上高を基に、2023年から2029年にかけての予測を地域別および市場セクター別に分析しています。市場は、米国、中国、欧州などの主要地域で成長が見込まれ、特に米国市場は2022年から2029年にかけての成長率が注目されています。主要企業には、Eurofins Discovery、Sygnature Discovery、Charles Riverなどが含まれ、2022年には上位2社が市場の大部分を占めました。
このレポートは、表現型創薬の製品タイプやアプリケーション別の市場シェア、成長機会を詳細に示しています。市場は、がん、ウイルス感染、遺伝病などのアプリケーションに分かれ、プラットフォームとサービスのタイプに基づいてセグメント化されています。
関連する質問
Eurofins Discovery, Sygnature Discovery, PsychoGenics, siTOOLs Biotech, PhoreMost, Charles River, MaxWell, Arctoris
製品セグメンテーションの重要なトレンド, 企業の市場参入戦略, 地理的フットプリントの分析
概要
このインサイトレポートは、世界の表現型薬物発見の状況について包括的な分析を提供し、製品セグメンテーション、企業形成、収益、市場シェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。また、このレポートは、表現型薬物発見のポートフォリオと能力、市場参入戦略、市場ポジション、地理的な足跡に焦点を当て、世界の表現型薬物発見市場が加速する中で、これらの企業の独自の位置をよりよく理解できるようにするために、主要なグローバル企業の戦略も分析しています。
このインサイトレポートは、表現型薬物発見のグローバルな展望を形成する主要な市場動向、要因、影響要因を評価し、タイプ、アプリケーション、地理、マーケットサイズ別に予測を分解し、新たな機会の出現ポイントを強調します。数百のボトムアップの定性および定量市場インプットに基づく透明性のある方法論を用いて、この研究の予測は、表現型薬物発見の現在の状態と将来の軌道に関する非常に細かな見解を提供します。
グローバル表現型ドラッグディスカバリー市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長すると予測されています。また、2023年から2029年にかけてCAGRはXX%の成長が見込まれています。
アメリカ合衆国の表現型薬剤発見市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると推定されており、2023年から2029年までの間にXX%の年平均成長率（CAGR）を示します。
中国の表現型薬物発見市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定され、2023年から2029年までの年平均成長率（CAGR）はXX%です。
ヨーロッパの表現型薬物発見市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年までの間にXX%のCAGRを記録する見込みです。
グローバルな主要表現型薬剤発見プレーヤーには、ユーロフィンズ・ディスカバリー、シグネチャー・ディスカバリー、サイコジェニクス、シツールズ・バイオテック、フォーレモスト、チャールズ・リバー、マックスウェル、アルクトリスなどが含まれます。収益の観点から、2022年には世界の2大企業がほぼXX%のシェアを占めました。
この報告書は、製品タイプ、アプリケーション、主要プレーヤー、および主要地域と国別の表現型薬物発見市場の包括的な概要、市場シェア、および成長機会を提示します。
市場セグメンテーション：
タイプ別セグメンテーション
プラットフォーム
サービス
アプリケーションによるセグメンテーション
癌
ウイルス感染
遺伝性疾患
その他
この報告書は地域別に市場を分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から得た情報や企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した結果に基づいて選定されています。
ユーロフィンズ・ディスカバリー
シグネチャー・ディスカバリー
サイコジェニクス
シツールズ バイオテック
フォアモスト
チャールズリバー
マックスウェル
アークトリス
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの表現型創薬市場規模、（2018年～2029年）
2.1.2 表現型創薬市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 表現型創薬セグメント、タイプ別
2.2.1 プラットフォーム
2.2.2 サービス
2.3 表現型創薬市場規模：タイプ別
2.3.1 表現型創薬市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの表現型創薬市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 表現型創薬セグメント、用途別
2.4.1 がん種
2.4.2 ウイルス感染
2.4.3 遺伝子疾患
2.4.4 その他
2.5 表現型創薬市場規模：用途別
2.5.1 表現型創薬市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの表現型創薬市場規模、市場シェア（用途別）（2018年～2023年）
3 表現型創薬市場規模：プレイヤー別
3.1 表現型創薬市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける表現型創薬市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける表現型創薬市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの表現型創薬市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 表現型創薬、地域別
4.1 表現型創薬市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける表現型創薬市場規模成長（2018年〜2023年）
4.3 APACにおける表現型創薬市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける表現型創薬市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける表現型創薬市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける表現型創薬市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける表現型創薬市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける表現型創薬市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける表現型創薬市場規模、地域別（2018年〜2023年）
6.2 APACにおける表現型創薬市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける表現型創薬市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの表現型創薬 国別（2018年～2023年）
7.2 ヨーロッパにおける表現型創薬市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける表現型創薬市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの表現型創薬 地域別（2018年～2023年）
8.2 中東・アフリカにおける表現型創薬市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける表現型創薬市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの表現型創薬市場、市場予測
10.1 グローバルの表現型創薬、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの表現型創薬、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの表現型創薬、市場予測
10.1.3 APACの表現型創薬、市場予測
10.1.4 ヨーロッパの表現型創薬、市場予測
10.1.5 中東・アフリカの表現型創薬、市場予測
10.2 アメリカズの表現型創薬、市場予測（国別）（2024年～2029年）
10.3 APACの表現型創薬、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの表現型創薬、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの表現型創薬、市場予測（地域別）（2024年～2029年）
10.6 グローバルの表現型創薬、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの表現型創薬、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery：企業情報
11.1.2 Eurofins Discovery：表現型創薬分野の提供製品
11.1.3 Eurofins Discovery：表現型創薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 Eurofins Discovery：主要事業概要
11.1.5 Eurofins Discovery：直近の展開
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery：企業情報
11.2.2 Sygnature Discovery：表現型創薬分野の提供製品
11.2.3 Sygnature Discovery：表現型創薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.2.4 Sygnature Discovery：主要事業概要
11.2.5 Sygnature Discovery：直近の展開
11.3 PsychoGenics
11.3.1 PsychoGenics：企業情報
11.3.2 PsychoGenics：表現型創薬分野の提供製品
11.3.3 PsychoGenics：表現型創薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 PsychoGenics：主要事業概要
11.3.5 PsychoGenics：直近の展開
11.4 siTOOLs Biotech
11.4.1 siTOOLs Biotech：企業情報
11.4.2 siTOOLs Biotech：表現型創薬分野の提供製品
11.4.3 siTOOLs Biotech：表現型創薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 siTOOLs Biotech：主要事業概要
11.4.5 siTOOLs Biotech：直近の展開
11.5 PhoreMost
11.5.1 PhoreMost：企業情報
11.5.2 PhoreMost：表現型創薬分野の提供製品
11.5.3 PhoreMost：表現型創薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.5.4 PhoreMost：主要事業概要
11.5.5 PhoreMost：直近の展開
11.6 Charles River
11.6.1 Charles River：企業情報
11.6.2 Charles River：表現型創薬分野の提供製品
11.6.3 Charles River：表現型創薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.6.4 Charles River：主要事業概要
11.6.5 Charles River：直近の展開
11.7 MaxWell
11.7.1 MaxWell：企業情報
11.7.2 MaxWell：表現型創薬分野の提供製品
11.7.3 MaxWell：表現型創薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 MaxWell：主要事業概要
11.7.5 MaxWell：直近の展開
11.8 Arctoris
11.8.1 Arctoris：企業情報
11.8.2 Arctoris：表現型創薬分野の提供製品
11.8.3 Arctoris：表現型創薬収益・グロスマージンおよび市場シェア（2018年～2023年）
11.8.4 Arctoris：主要事業概要
11.8.5 Arctoris：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Phenotypic Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phenotypic Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phenotypic Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phenotypic Drug Discovery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phenotypic Drug Discovery.
The global Phenotypic Drug Discovery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Phenotypic Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Phenotypic Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Phenotypic Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Phenotypic Drug Discovery players cover Eurofins Discovery, Sygnature Discovery, PsychoGenics, siTOOLs Biotech, PhoreMost, Charles River, MaxWell and Arctoris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Phenotypic Drug Discovery market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Platform
Service
Segmentation by application
Cancer
Viral Infection
Genetic Disease
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Discovery
Sygnature Discovery
PsychoGenics
siTOOLs Biotech
PhoreMost
Charles River
MaxWell
Arctoris
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Phenotypic Drug Discovery Market Size 2018-2029
2.1.2 Phenotypic Drug Discovery Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Phenotypic Drug Discovery Segment by Type
2.2.1 Platform
2.2.2 Service
2.3 Phenotypic Drug Discovery Market Size by Type
2.3.1 Phenotypic Drug Discovery Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Phenotypic Drug Discovery Market Size Market Share by Type (2018-2023)
2.4 Phenotypic Drug Discovery Segment by Application
2.4.1 Cancer
2.4.2 Viral Infection
2.4.3 Genetic Disease
2.4.4 Others
2.5 Phenotypic Drug Discovery Market Size by Application
2.5.1 Phenotypic Drug Discovery Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Phenotypic Drug Discovery Market Size Market Share by Application (2018-2023)
3 Phenotypic Drug Discovery Market Size by Player
3.1 Phenotypic Drug Discovery Market Size Market Share by Players
3.1.1 Global Phenotypic Drug Discovery Revenue by Players (2018-2023)
3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2018-2023)
3.2 Global Phenotypic Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Phenotypic Drug Discovery by Regions
4.1 Phenotypic Drug Discovery Market Size by Regions (2018-2023)
4.2 Americas Phenotypic Drug Discovery Market Size Growth (2018-2023)
4.3 APAC Phenotypic Drug Discovery Market Size Growth (2018-2023)
4.4 Europe Phenotypic Drug Discovery Market Size Growth (2018-2023)
4.5 Middle East & Africa Phenotypic Drug Discovery Market Size Growth (2018-2023)
5 Americas
5.1 Americas Phenotypic Drug Discovery Market Size by Country (2018-2023)
5.2 Americas Phenotypic Drug Discovery Market Size by Type (2018-2023)
5.3 Americas Phenotypic Drug Discovery Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phenotypic Drug Discovery Market Size by Region (2018-2023)
6.2 APAC Phenotypic Drug Discovery Market Size by Type (2018-2023)
6.3 APAC Phenotypic Drug Discovery Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Phenotypic Drug Discovery by Country (2018-2023)
7.2 Europe Phenotypic Drug Discovery Market Size by Type (2018-2023)
7.3 Europe Phenotypic Drug Discovery Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Phenotypic Drug Discovery by Region (2018-2023)
8.2 Middle East & Africa Phenotypic Drug Discovery Market Size by Type (2018-2023)
8.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Phenotypic Drug Discovery Market Forecast
10.1 Global Phenotypic Drug Discovery Forecast by Regions (2024-2029)
10.1.1 Global Phenotypic Drug Discovery Forecast by Regions (2024-2029)
10.1.2 Americas Phenotypic Drug Discovery Forecast
10.1.3 APAC Phenotypic Drug Discovery Forecast
10.1.4 Europe Phenotypic Drug Discovery Forecast
10.1.5 Middle East & Africa Phenotypic Drug Discovery Forecast
10.2 Americas Phenotypic Drug Discovery Forecast by Country (2024-2029)
10.2.1 United States Phenotypic Drug Discovery Market Forecast
10.2.2 Canada Phenotypic Drug Discovery Market Forecast
10.2.3 Mexico Phenotypic Drug Discovery Market Forecast
10.2.4 Brazil Phenotypic Drug Discovery Market Forecast
10.3 APAC Phenotypic Drug Discovery Forecast by Region (2024-2029)
10.3.1 China Phenotypic Drug Discovery Market Forecast
10.3.2 Japan Phenotypic Drug Discovery Market Forecast
10.3.3 Korea Phenotypic Drug Discovery Market Forecast
10.3.4 Southeast Asia Phenotypic Drug Discovery Market Forecast
10.3.5 India Phenotypic Drug Discovery Market Forecast
10.3.6 Australia Phenotypic Drug Discovery Market Forecast
10.4 Europe Phenotypic Drug Discovery Forecast by Country (2024-2029)
10.4.1 Germany Phenotypic Drug Discovery Market Forecast
10.4.2 France Phenotypic Drug Discovery Market Forecast
10.4.3 UK Phenotypic Drug Discovery Market Forecast
10.4.4 Italy Phenotypic Drug Discovery Market Forecast
10.4.5 Russia Phenotypic Drug Discovery Market Forecast
10.5 Middle East & Africa Phenotypic Drug Discovery Forecast by Region (2024-2029)
10.5.1 Egypt Phenotypic Drug Discovery Market Forecast
10.5.2 South Africa Phenotypic Drug Discovery Market Forecast
10.5.3 Israel Phenotypic Drug Discovery Market Forecast
10.5.4 Turkey Phenotypic Drug Discovery Market Forecast
10.5.5 GCC Countries Phenotypic Drug Discovery Market Forecast
10.6 Global Phenotypic Drug Discovery Forecast by Type (2024-2029)
10.7 Global Phenotypic Drug Discovery Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Information
11.1.2 Eurofins Discovery Phenotypic Drug Discovery Product Offered
11.1.3 Eurofins Discovery Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Eurofins Discovery Main Business Overview
11.1.5 Eurofins Discovery Latest Developments
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery Company Information
11.2.2 Sygnature Discovery Phenotypic Drug Discovery Product Offered
11.2.3 Sygnature Discovery Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Sygnature Discovery Main Business Overview
11.2.5 Sygnature Discovery Latest Developments
11.3 PsychoGenics
11.3.1 PsychoGenics Company Information
11.3.2 PsychoGenics Phenotypic Drug Discovery Product Offered
11.3.3 PsychoGenics Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 PsychoGenics Main Business Overview
11.3.5 PsychoGenics Latest Developments
11.4 siTOOLs Biotech
11.4.1 siTOOLs Biotech Company Information
11.4.2 siTOOLs Biotech Phenotypic Drug Discovery Product Offered
11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 siTOOLs Biotech Main Business Overview
11.4.5 siTOOLs Biotech Latest Developments
11.5 PhoreMost
11.5.1 PhoreMost Company Information
11.5.2 PhoreMost Phenotypic Drug Discovery Product Offered
11.5.3 PhoreMost Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 PhoreMost Main Business Overview
11.5.5 PhoreMost Latest Developments
11.6 Charles River
11.6.1 Charles River Company Information
11.6.2 Charles River Phenotypic Drug Discovery Product Offered
11.6.3 Charles River Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Charles River Main Business Overview
11.6.5 Charles River Latest Developments
11.7 MaxWell
11.7.1 MaxWell Company Information
11.7.2 MaxWell Phenotypic Drug Discovery Product Offered
11.7.3 MaxWell Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 MaxWell Main Business Overview
11.7.5 MaxWell Latest Developments
11.8 Arctoris
11.8.1 Arctoris Company Information
11.8.2 Arctoris Phenotypic Drug Discovery Product Offered
11.8.3 Arctoris Phenotypic Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Arctoris Main Business Overview
11.8.5 Arctoris Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Phenotypic Drug Discovery Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Platform Table 3. Major Players of Service Table 4. Phenotypic Drug Discovery Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 5. Global Phenotypic Drug Discovery Market Size by Type (2018-2023) & ($ Millions) Table 6. Global Phenotypic Drug Discovery Market Size Market Share by Type (2018-2023) Table 7. Phenotypic Drug Discovery Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 8. Global Phenotypic Drug Discovery Market Size by Application (2018-2023) & ($ Millions) Table 9. Global Phenotypic Drug Discovery Market Size Market Share by Application (2018-2023) Table 10. Global Phenotypic Drug Discovery Revenue by Players (2018-2023) & ($ Millions) Table 11. Global Phenotypic Drug Discovery Revenue Market Share by Player (2018-2023) Table 12. Phenotypic Drug Discovery Key Players Head office and Products Offered Table 13. Phenotypic Drug Discovery Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Phenotypic Drug Discovery Market Size by Regions 2018-2023 & ($ Millions) Table 17. Global Phenotypic Drug Discovery Market Size Market Share by Regions (2018-2023) Table 18. Global Phenotypic Drug Discovery Revenue by Country/Region (2018-2023) & ($ millions) Table 19. Global Phenotypic Drug Discovery Revenue Market Share by Country/Region (2018-2023) Table 20. Americas Phenotypic Drug Discovery Market Size by Country (2018-2023) & ($ Millions) Table 21. Americas Phenotypic Drug Discovery Market Size Market Share by Country (2018-2023) Table 22. Americas Phenotypic Drug Discovery Market Size by Type (2018-2023) & ($ Millions) Table 23. Americas Phenotypic Drug Discovery Market Size Market Share by Type (2018-2023) Table 24. Americas Phenotypic Drug Discovery Market Size by Application (2018-2023) & ($ Millions) Table 25. Americas Phenotypic Drug Discovery Market Size Market Share by Application (2018-2023) Table 26. APAC Phenotypic Drug Discovery Market Size by Region (2018-2023) & ($ Millions) Table 27. APAC Phenotypic Drug Discovery Market Size Market Share by Region (2018-2023) Table 28. APAC Phenotypic Drug Discovery Market Size by Type (2018-2023) & ($ Millions) Table 29. APAC Phenotypic Drug Discovery Market Size Market Share by Type (2018-2023) Table 30. APAC Phenotypic Drug Discovery Market Size by Application (2018-2023) & ($ Millions) Table 31. APAC Phenotypic Drug Discovery Market Size Market Share by Application (2018-2023) Table 32. Europe Phenotypic Drug Discovery Market Size by Country (2018-2023) & ($ Millions) Table 33. Europe Phenotypic Drug Discovery Market Size Market Share by Country (2018-2023) Table 34. Europe Phenotypic Drug Discovery Market Size by Type (2018-2023) & ($ Millions) Table 35. Europe Phenotypic Drug Discovery Market Size Market Share by Type (2018-2023) Table 36. Europe Phenotypic Drug Discovery Market Size by Application (2018-2023) & ($ Millions) Table 37. Europe Phenotypic Drug Discovery Market Size Market Share by Application (2018-2023) Table 38. Middle East & Africa Phenotypic Drug Discovery Market Size by Region (2018-2023) & ($ Millions) Table 39. Middle East & Africa Phenotypic Drug Discovery Market Size Market Share by Region (2018-2023) Table 40. Middle East & Africa Phenotypic Drug Discovery Market Size by Type (2018-2023) & ($ Millions) Table 41. Middle East & Africa Phenotypic Drug Discovery Market Size Market Share by Type (2018-2023) Table 42. Middle East & Africa Phenotypic Drug Discovery Market Size by Application (2018-2023) & ($ Millions) Table 43. Middle East & Africa Phenotypic Drug Discovery Market Size Market Share by Application (2018-2023) Table 44. Key Market Drivers & Growth Opportunities of Phenotypic Drug Discovery Table 45. Key Market Challenges & Risks of Phenotypic Drug Discovery Table 46. Key Industry Trends of Phenotypic Drug Discovery Table 47. Global Phenotypic Drug Discovery Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 48. Global Phenotypic Drug Discovery Market Size Market Share Forecast by Regions (2024-2029) Table 49. Global Phenotypic Drug Discovery Market Size Forecast by Type (2024-2029) & ($ Millions) Table 50. Global Phenotypic Drug Discovery Market Size Forecast by Application (2024-2029) & ($ Millions) Table 51. Eurofins Discovery Details, Company Type, Phenotypic Drug Discovery Area Served and Its Competitors Table 52. Eurofins Discovery Phenotypic Drug Discovery Product Offered Table 53. Eurofins Discovery Phenotypic Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 54. Eurofins Discovery Main Business Table 55. Eurofins Discovery Latest Developments Table 56. Sygnature Discovery Details, Company Type, Phenotypic Drug Discovery Area Served and Its Competitors Table 57. Sygnature Discovery Phenotypic Drug Discovery Product Offered Table 58. Sygnature Discovery Main Business Table 59. Sygnature Discovery Phenotypic Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 60. Sygnature Discovery Latest Developments Table 61. PsychoGenics Details, Company Type, Phenotypic Drug Discovery Area Served and Its Competitors Table 62. PsychoGenics Phenotypic Drug Discovery Product Offered Table 63. PsychoGenics Main Business Table 64. PsychoGenics Phenotypic Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 65. PsychoGenics Latest Developments Table 66. siTOOLs Biotech Details, Company Type, Phenotypic Drug Discovery Area Served and Its Competitors Table 67. siTOOLs Biotech Phenotypic Drug Discovery Product Offered Table 68. siTOOLs Biotech Main Business Table 69. siTOOLs Biotech Phenotypic Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 70. siTOOLs Biotech Latest Developments Table 71. PhoreMost Details, Company Type, Phenotypic Drug Discovery Area Served and Its Competitors Table 72. PhoreMost Phenotypic Drug Discovery Product Offered Table 73. PhoreMost Main Business Table 74. PhoreMost Phenotypic Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 75. PhoreMost Latest Developments Table 76. Charles River Details, Company Type, Phenotypic Drug Discovery Area Served and Its Competitors Table 77. Charles River Phenotypic Drug Discovery Product Offered Table 78. Charles River Main Business Table 79. Charles River Phenotypic Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 80. Charles River Latest Developments Table 81. MaxWell Details, Company Type, Phenotypic Drug Discovery Area Served and Its Competitors Table 82. MaxWell Phenotypic Drug Discovery Product Offered Table 83. MaxWell Main Business Table 84. MaxWell Phenotypic Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 85. MaxWell Latest Developments Table 86. Arctoris Details, Company Type, Phenotypic Drug Discovery Area Served and Its Competitors Table 87. Arctoris Phenotypic Drug Discovery Product Offered Table 88. Arctoris Main Business Table 89. Arctoris Phenotypic Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 90. Arctoris Latest Developments List of Figures Figure 1. Phenotypic Drug Discovery Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Phenotypic Drug Discovery Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Phenotypic Drug Discovery Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Phenotypic Drug Discovery Sales Market Share by Country/Region (2022) Figure 8. Phenotypic Drug Discovery Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Phenotypic Drug Discovery Market Size Market Share by Type in 2022 Figure 10. Phenotypic Drug Discovery in Cancer Figure 11. Global Phenotypic Drug Discovery Market: Cancer (2018-2023) & ($ Millions) Figure 12. Phenotypic Drug Discovery in Viral Infection Figure 13. Global Phenotypic Drug Discovery Market: Viral Infection (2018-2023) & ($ Millions) Figure 14. Phenotypic Drug Discovery in Genetic Disease Figure 15. Global Phenotypic Drug Discovery Market: Genetic Disease (2018-2023) & ($ Millions) Figure 16. Phenotypic Drug Discovery in Others Figure 17. Global Phenotypic Drug Discovery Market: Others (2018-2023) & ($ Millions) Figure 18. Global Phenotypic Drug Discovery Market Size Market Share by Application in 2022 Figure 19. Global Phenotypic Drug Discovery Revenue Market Share by Player in 2022 Figure 20. Global Phenotypic Drug Discovery Market Size Market Share by Regions (2018-2023) Figure 21. Americas Phenotypic Drug Discovery Market Size 2018-2023 ($ Millions) Figure 22. APAC Phenotypic Drug Discovery Market Size 2018-2023 ($ Millions) Figure 23. Europe Phenotypic Drug Discovery Market Size 2018-2023 ($ Millions) Figure 24. Middle East & Africa Phenotypic Drug Discovery Market Size 2018-2023 ($ Millions) Figure 25. Americas Phenotypic Drug Discovery Value Market Share by Country in 2022 Figure 26. United States Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 27. Canada Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 28. Mexico Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 29. Brazil Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 30. APAC Phenotypic Drug Discovery Market Size Market Share by Region in 2022 Figure 31. APAC Phenotypic Drug Discovery Market Size Market Share by Type in 2022 Figure 32. APAC Phenotypic Drug Discovery Market Size Market Share by Application in 2022 Figure 33. China Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 34. Japan Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 35. Korea Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 36. Southeast Asia Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 37. India Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 38. Australia Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 39. Europe Phenotypic Drug Discovery Market Size Market Share by Country in 2022 Figure 40. Europe Phenotypic Drug Discovery Market Size Market Share by Type (2018-2023) Figure 41. Europe Phenotypic Drug Discovery Market Size Market Share by Application (2018-2023) Figure 42. Germany Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 43. France Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 44. UK Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 45. Italy Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 46. Russia Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 47. Middle East & Africa Phenotypic Drug Discovery Market Size Market Share by Region (2018-2023) Figure 48. Middle East & Africa Phenotypic Drug Discovery Market Size Market Share by Type (2018-2023) Figure 49. Middle East & Africa Phenotypic Drug Discovery Market Size Market Share by Application (2018-2023) Figure 50. Egypt Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 51. South Africa Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 52. Israel Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 53. Turkey Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 54. GCC Country Phenotypic Drug Discovery Market Size Growth 2018-2023 ($ Millions) Figure 55. Americas Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 56. APAC Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 57. Europe Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 58. Middle East & Africa Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 59. United States Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 60. Canada Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 61. Mexico Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 62. Brazil Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 63. China Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 64. Japan Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 65. Korea Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 66. Southeast Asia Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 67. India Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 68. Australia Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 69. Germany Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 70. France Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 71. UK Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 72. Italy Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 73. Russia Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 74. Spain Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 75. Egypt Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 76. South Africa Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 77. Israel Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 78. Turkey Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 79. GCC Countries Phenotypic Drug Discovery Market Size 2024-2029 ($ Millions) Figure 80. Global Phenotypic Drug Discovery Market Size Market Share Forecast by Type (2024-2029) Figure 81. Global Phenotypic Drug Discovery Market Size Market Share Forecast by Application (2024-2029)
